GSK2857916: Ph I BMA117159 data

Data from 30 patients with relapsed or refractory MM in the dose-escalation portion of the open-label, international Phase I BMA117159 trial showed that 0.03 to 4.6 mg/kg doses of IV GSK2857916 every ...